Global Levothyroxine 麻豆原创 Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Publication ID:

PB506256817

Publication Date:

June 10, 2025

Pages:

139

Publisher:

MRRPB5

Countries:

Global [1]

USD 5,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

In 2024, the global market size of Levothyroxine was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.

Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body"s energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.

Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
In United States, the key Levothyroxine manufacturers are Abbott Ltd, Alara Pharm (Sandoz), Forest (Actavis), Merck Serono, Piramal Healthcare, Mylan, KING PHARMS R AND D, Jerome Stevens etc. Top 3 companies occupied about 69% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Levothyroxine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levothyroxine.
The Levothyroxine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Levothyroxine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levothyroxine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
Segment听by Type
Slice in Solid
In Bottles for Injection
Segment听by Application
Hospitals
Chemist's Shops
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Levothyroxine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Levothyroxine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Levothyroxine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Levothyroxine Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Levothyroxine 麻豆原创 Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Slice in Solid
1.2.3 In Bottles for Injection
1.3 麻豆原创 by Application
1.3.1 Global Levothyroxine 麻豆原创 Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Chemist's Shops
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Levothyroxine 麻豆原创 Size Estimates and Forecasts
2.1.1 Global Levothyroxine Revenue 2020-2031
2.1.2 Global Levothyroxine Sales 2020-2031
2.2 Levothyroxine 麻豆原创 Size by Region: 2024 Versus 2031
2.3 Levothyroxine Sales by Region (2020-2031)
2.3.1 Global Levothyroxine Sales by Region: 2020-2025
2.3.2 Global Levothyroxine Sales Forecast by Region (2026-2031)
2.3.3 Global Levothyroxine Sales 麻豆原创 Share by Region (2020-2031)
2.4 Levothyroxine 麻豆原创 Estimates and Projections by Region (2026-2031)
2.4.1 Global Levothyroxine Revenue by Region: 2020-2025
2.4.2 Global Levothyroxine Revenue Forecast by Region (2026-2031)
2.4.3 Global Levothyroxine Revenue 麻豆原创 Share by Region (2020-2031)
3 麻豆原创 Segments
3.1 Breakdown Data by Type
3.1.1 Global Levothyroxine Sales by Type (2020-2031)
3.1.1.1 Global Levothyroxine Sales Volume by Type (2020-2031)
3.1.1.2 Global Levothyroxine Sales 麻豆原创 Share by Type (2020-2031)
3.1.2 Global Levothyroxine Revenue by Type (2020-2031)
3.1.2.1 Global Levothyroxine Revenue by Type (2020-2031)
3.1.2.2 Global Levothyroxine Revenue 麻豆原创 Share by Type (2020-2031)
3.1.3 Levothyroxine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Levothyroxine Sales by Application (2020-2031)
3.2.1.1 Global Levothyroxine Sales Volume by Application (2020-2031)
3.2.1.2 Global Levothyroxine Sales 麻豆原创 Share by Application (2020-2031)
3.2.2 Global Levothyroxine Revenue by Application (2020-2031)
3.2.2.1 Global Levothyroxine Revenue by Application (2020-2031)
3.2.2.2 Global Levothyroxine Revenue 麻豆原创 Share by Application (2020-2031)
3.2.3 Levothyroxine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Slice in Solid of Levothyroxine Revenue 麻豆原创 Share by Application
3.3.2 In Bottles for Injection of Levothyroxine Revenue 麻豆原创 Share by Application
4 Global Levothyroxine by Manufacturers
4.1 Global Top Levothyroxine Manufacturers by Sales (2020-2025)
4.1.1 Global Levothyroxine Sales by Manufacturer (2020-2025)
4.1.2 Global Levothyroxine Sales 麻豆原创 Share by Manufacturer (2020-2025)
4.2 Global Top Levothyroxine Manufacturers by Revenue (2020-2025)
4.2.1 Global Levothyroxine Revenue by Manufacturer (2020-2025)
4.2.2 Global Levothyroxine Revenue Share by Manufacturer (2020-2025)
4.3 Global Levothyroxine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Levothyroxine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Levothyroxine 麻豆原创 Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Levothyroxine 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Levothyroxine Manufacturing Base Distribution, Product Type
4.5.1 Levothyroxine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Levothyroxine 麻豆原创
4.5.3 Manufacturers Levothyroxine Product Type and Application
4.5.4 Slice in Solid 麻豆原创 Sales of Levothyroxine by Manufacturer
4.5.5 In Bottles for Injection 麻豆原创 Sales of Levothyroxine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Abbott Ltd
5.1.1 Abbott Ltd Company Information
5.1.2 Abbott Ltd Description, Business Overview
5.1.3 Abbott Ltd Levothyroxine Products Offered
5.1.4 Abbott Ltd Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Abbott Ltd Levothyroxine Sales by Product in 2024
5.1.6 Abbott Ltd Levothyroxine Sales by Application in 2024
5.1.7 Abbott Ltd Levothyroxine Sales by Geographic Area in 2024
5.1.8 Abbott Ltd Recent Developments
5.2 Alara Pharm (Sandoz)
5.2.1 Alara Pharm (Sandoz) Company Information
5.2.2 Alara Pharm (Sandoz) Description, Business Overview
5.2.3 Alara Pharm (Sandoz) Levothyroxine Products Offered
5.2.4 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Alara Pharm (Sandoz) Levothyroxine Sales by Product in 2024
5.2.6 Alara Pharm (Sandoz) Levothyroxine Sales by Application in 2024
5.2.7 Alara Pharm (Sandoz) Levothyroxine Sales by Geographic Area in 2024
5.2.8 Alara Pharm (Sandoz) Recent Developments
5.3 Forest (Actavis)
5.3.1 Forest (Actavis) Company Information
5.3.2 Forest (Actavis) Description, Business Overview
5.3.3 Forest (Actavis) Levothyroxine Products Offered
5.3.4 Forest (Actavis) Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Forest (Actavis) Levothyroxine Sales by Product in 2024
5.3.6 Forest (Actavis) Levothyroxine Sales by Application in 2024
5.3.7 Forest (Actavis) Levothyroxine Sales by Geographic Area in 2024
5.3.8 Forest (Actavis) Recent Developments
5.4 Merck Serono
5.4.1 Merck Serono Company Information
5.4.2 Merck Serono Description, Business Overview
5.4.3 Merck Serono Levothyroxine Products Offered
5.4.4 Merck Serono Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Merck Serono Levothyroxine Sales by Product in 2024
5.4.6 Merck Serono Levothyroxine Sales by Application in 2024
5.4.7 Merck Serono Levothyroxine Sales by Geographic Area in 2024
5.4.8 Merck Serono Recent Developments
5.5 Piramal Healthcare
5.5.1 Piramal Healthcare Company Information
5.5.2 Piramal Healthcare Description, Business Overview
5.5.3 Piramal Healthcare Levothyroxine Products Offered
5.5.4 Piramal Healthcare Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Piramal Healthcare Levothyroxine Sales by Product in 2024
5.5.6 Piramal Healthcare Levothyroxine Sales by Application in 2024
5.5.7 Piramal Healthcare Levothyroxine Sales by Geographic Area in 2024
5.5.8 Piramal Healthcare Recent Developments
5.6 Mylan
5.6.1 Mylan Company Information
5.6.2 Mylan Description, Business Overview
5.6.3 Mylan Levothyroxine Products Offered
5.6.4 Mylan Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mylan Levothyroxine Sales by Product in 2024
5.6.6 Mylan Levothyroxine Sales by Application in 2024
5.6.7 Mylan Levothyroxine Sales by Geographic Area in 2024
5.6.8 Mylan Recent Developments
5.7 KING PHARMS R AND D
5.7.1 KING PHARMS R AND D Company Information
5.7.2 KING PHARMS R AND D Description, Business Overview
5.7.3 KING PHARMS R AND D Levothyroxine Products Offered
5.7.4 KING PHARMS R AND D Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 KING PHARMS R AND D Levothyroxine Sales by Product in 2024
5.7.6 KING PHARMS R AND D Levothyroxine Sales by Application in 2024
5.7.7 KING PHARMS R AND D Levothyroxine Sales by Geographic Area in 2024
5.7.8 KING PHARMS R AND D Recent Developments
5.8 Jerome Stevens
5.8.1 Jerome Stevens Company Information
5.8.2 Jerome Stevens Description, Business Overview
5.8.3 Jerome Stevens Levothyroxine Products Offered
5.8.4 Jerome Stevens Levothyroxine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Jerome Stevens Levothyroxine Sales by Product in 2024
5.8.6 Jerome Stevens Levothyroxine Sales by Application in 2024
5.8.7 Jerome Stevens Levothyroxine Sales by Geographic Area in 2024
5.8.8 Jerome Stevens Recent Developments
6 North America
6.1 North America Levothyroxine 麻豆原创 Size YoY Growth 2020-2031
6.2 North America Levothyroxine 麻豆原创 Facts & Figures by Country
6.2.1 North America Levothyroxine Sales by Country (2020-2031)
6.2.2 North America Levothyroxine Revenue by Country (2020-2031)
6.3 North America Levothyroxine Sales by Type (2020-2025)
6.4 North America Levothyroxine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Levothyroxine 麻豆原创 Size YoY Growth 2020-2031
7.2 Asia-Pacific Levothyroxine 麻豆原创 Facts & Figures by Region
7.2.1 Asia-Pacific Levothyroxine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Levothyroxine Revenue by Region (2020-2031)
7.3 Asia-Pacific Levothyroxine Sales by Type (2020-2025)
7.4 Asia-Pacific Levothyroxine Sales by Application (2020-2025)
8 Europe
8.1 Europe Levothyroxine 麻豆原创 Size YoY Growth 2020-2031
8.2 Europe Levothyroxine 麻豆原创 Facts & Figures by Country
8.2.1 Europe Levothyroxine Sales by Country (2020-2031)
8.2.2 Europe Levothyroxine Revenue by Country (2020-2031)
8.3 Europe Levothyroxine Sales by Type (2020-2025)
8.4 Europe Levothyroxine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Levothyroxine 麻豆原创 Size YoY Growth 2020-2031
9.2 Latin America Levothyroxine 麻豆原创 Facts & Figures by Country
9.2.1 Latin America Levothyroxine Sales by Country (2020-2031)
9.2.2 Latin America Levothyroxine Revenue by Country (2020-2031)
9.3 Latin America Levothyroxine Sales by Type (2020-2025)
9.4 Latin America Levothyroxine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Levothyroxine 麻豆原创 Size YoY Growth 2020-2031
10.2 Middle East and Africa Levothyroxine 麻豆原创 Facts & Figures by Country
10.2.1 Middle East and Africa Levothyroxine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Levothyroxine Revenue by Country (2020-2031)
10.3 Middle East and Africa Levothyroxine Sales by Type (2020-2025)
10.4 Middle East and Africa Levothyroxine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Levothyroxine Supply Chain Analysis
11.2 Levothyroxine Key Raw Materials and Upstream Suppliers
11.3 Levothyroxine Clients Analysis
11.4 Levothyroxine Sales Channel and Sales Model Analysis
11.4.1 Levothyroxine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Levothyroxine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Levothyroxine Distributors
12 Levothyroxine 麻豆原创 Dynamics
12.1 Levothyroxine Industry Trends
12.2 Levothyroxine 麻豆原创 Drivers
12.3 Levothyroxine 麻豆原创 Challenges
12.4 Levothyroxine 麻豆原创 Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 麻豆原创 Size Estimation
14.1.1.3 麻豆原创 Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Companies Mentioned:

Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.